載入...
Dissolution enhancement of efavirenz by solid dispersion and PEGylation techniques
BACKGROUND: Efavirenz is the preferred nonnucleotide reverse transcriptase inhibitor for first-line antiretroviral treatment in many countries. It is orally active and is specific for human immunodeficiency virus type 1. Its effectiveness can be attributed to its long half-life, which is 52–76 h aft...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Medknow Publications & Media Pvt Ltd
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3465113/ https://ncbi.nlm.nih.gov/pubmed/23071917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-973X.76726 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|